Core Insights - Rippling, an HR software startup, raised $450 million in Series G funding, achieving a valuation of $16.8 billion, focusing on global revenue growth over immediate profitability [1][4][5] Funding and Valuation - The funding round included participation from notable investors such as Y Combinator, Elad Gil, Sands Capital, GIC, and Goldman Sachs Growth [2] - The new valuation of $16.8 billion marks an increase from the previous valuation of $13.5 billion in early 2024 [4] Employee Equity and IPO Plans - Rippling plans to repurchase up to $200 million of equity from current and former employees through a tender offer, which may become an annual event [2][3] - The CEO stated that the company does not have immediate plans for an IPO, emphasizing the need for profitability before considering going public [4][6] Business Performance and Strategy - Rippling has surpassed $100 million in annual recurring revenue and serves over 20,000 customers with a suite of more than 20 products [5] - The company is prioritizing growth over profitability, indicating a strategic choice to expand rapidly rather than slow down for immediate profit [6] Legal Challenges - Rippling is involved in ongoing legal disputes with competitor Deel, including allegations of corporate espionage, which have raised questions about competitive practices in the tech industry [7][8]

Core Insights - Mineralys Therapeutics, Inc. is focused on developing innovative therapies for cardiovascular and renal diseases, addressing unmet medical needs through advanced research and development efforts [1] - The company is competing within the pharmaceutical sector, aiming to bring effective treatments to market and challenge other companies in the same space [1] Financial Performance - On March 13, 2026, a price target of $30 was set for MLYS by Dennis Ding from Jefferies, indicating a potential upside of approximately 14.37% from the trading price of $26.23 at that time [2] - MLYS's Q4 2025 earnings call provided insights into its financial performance and strategic initiatives, highlighting significant developments and plans for growth [3] - Currently, MLYS is priced at $26.19, reflecting a decrease of 2.96% with a drop of $0.80, and has fluctuated between a low of $25.45 and a high of $28.65 during the day [4] - Over the past year, MLYS has experienced significant volatility, reaching a high of $47.65 and a low of $10.44 [4][6] - The company's market capitalization is approximately $1.74 billion, indicating its size and market presence [5] - Today's trading volume for MLYS on NASDAQ is 1,380,806 shares, reflecting active investor interest and engagement [5]

We'd love to be your preferred source for news. Target will begin lowering prices on 3,000 items this month in its latest move to support the company's long- term, sustainable growth. By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions . Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no addition ...

Spanish Broadcasting System, Inc. Enters into Forbearance Agreement with Majority Bondholders Following Notes Maturity Accessibility Statement Skip NavigationMIAMI, March 13, 2026 /PRNewswire/ -- Spanish Broadcasting System, Inc. (the "Company") today provided an update regarding its 9.750% Senior Secured Notes due 2026 (the "Notes"), which matured on March 1, 2026.The Company has been engaged in constructive discussions with holders representing a majority of the outstanding principal amount of the Notes r ...

Core Insights - The major indexes experienced a third consecutive weekly decline, indicating a potential trend in market performance [1] Group 1 - The decline in major indexes suggests ongoing volatility in the market, which may impact investor sentiment and trading strategies [1]

Core Viewpoint - Barclays has raised its 2026 Brent crude oil price forecast to $85 per barrel due to ongoing supply disruptions linked to the Iran war, which have significantly reduced oil flows through the Strait of Hormuz [1] Group 1 - Barclays' updated forecast reflects a response to geopolitical tensions affecting oil supply [1] - The reduction in oil flows through the Strait of Hormuz is a critical factor influencing the price forecast [1]

Core Viewpoint - American Salars Lithium Inc. has arranged to settle outstanding indebtedness of $129,000 through the issuance of 600,000 common shares at a price of $0.215 per share [1]. Group 1: Debt Settlement Details - The debt settlement will involve a hold period of four months and one day from the date of issuance [2]. - The settlement includes $43,000 owed to the Company's CEO, Nick Horsley's management company, qualifying it as a related party transaction under Multilateral Instrument 61-101 [3]. - The Company plans to rely on exemptions from formal valuation and minority approval requirements, as the fair market value of the debt settlement does not exceed 25% of the Company's market capitalization [3]. Group 2: Company Overview - American Salars Lithium is focused on exploring and developing high-value battery metals projects to cater to the growing electric vehicle market [4].

Core Insights - Ocumetics Technology Corp. has issued 500,000 incentive stock options to Howard Group Inc. as part of their investor relations agreement [1] - Each option allows Howard Group to purchase one common share at an exercise price of $0.42 for two years, with quarterly vesting over twelve months [2] - The common shares from the stock options will have a four-month resale restriction from the grant date [2] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions [3] - The company aims to transform ophthalmology through innovative intraocular lenses and other vision-enhancing technologies [3] - Ocumetics is currently in the early feasibility study phase for a new intraocular lens designed to eliminate the need for corrective lenses, allowing natural focus adjustment [4]

Core Viewpoint - CEA Industries Inc. is facing a consent solicitation from YZILabs Management Ltd. to add up to seven directors to its Board, which could lead to a transfer of control to YZILabs, raising concerns about the interests of existing stockholders [2][3][5]. Group 1: Consent Solicitation Details - YZILabs has submitted a Request Letter to the Board to set a record date for its consent solicitation process [2][4]. - The current Board consists of six directors, and adding seven nominees from YZILabs would effectively transfer control to YZILabs [3]. - Only stockholders holding shares as of the record date will be eligible to vote on YZILabs' proposals, including the election of its director nominees [4]. Group 2: Concerns Raised by the Board - The Board has expressed concerns that the proposed nominees from YZILabs are closely associated with Changpeng Zhao (CZ) and his affiliates, which could lead to conflicts of interest [4][5]. - If YZILabs gains control, it could result in the Company purchasing BNB at inflated prices or approving transactions that do not benefit the Company [5]. - The Board is committed to objectively assessing YZILabs' candidates based on their potential to enhance the Board's skills and independent oversight [6]. Group 3: Board's Actions and Statements - The Board is currently reviewing the Request Letter to ensure compliance with the Company's bylaws [7]. - If the Request Letter is deemed valid, the Board will announce a record date for stockholders entitled to participate in the consent process [7]. - The Board emphasizes that stockholders are not required to take any action at this time [8].

Core Viewpoint - CEA Industries Inc. is facing a consent solicitation from YZILabs Management Ltd. to add up to seven directors to its Board, which could lead to a transfer of control to YZILabs, raising concerns about the interests of existing stockholders [2][3][5]. Group 1: Consent Solicitation Details - YZILabs has submitted a Request Letter to the Board to set a record date for its consent solicitation process [2][4]. - The Request Letter is a necessary step for YZILabs to potentially gain control of the Board, which currently has six directors [3][4]. - The Board is reviewing the Request Letter to ensure compliance with the Company's bylaws before announcing a record date for stockholders eligible to vote [7]. Group 2: Implications of Control Transfer - If YZILabs gains control, it could lead to decisions that may not align with the best interests of existing stockholders, such as purchasing BNB at inflated prices from close associates of Changpeng Zhao [5][6]. - The Board emphasizes the importance of independent oversight and is committed to evaluating YZILabs' director nominees based on their potential contributions to the Board's existing skills and expertise [6][8]. Group 3: Company Background - CEA Industries Inc. is a growth-oriented company focused on building leading businesses in consumer markets, including managing the world's largest corporate treasury of BNB [9].